Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -2.45 is 134% below its 5-year average of -1.05, near the low end of its 5-year range (-2.75–1.04).
As of the fiscal period ended Tuesday, June 30, 2026. 4.85% below its 12-month average of -2.34.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -2.45.
DEBT TO EQUITY RATIO
-2.45
DEBT TO EQUITY RATIO AVG TTM
-2.34
DEBT TO EQUITY RATIO AVG 3Y
-2.12
DEBT TO EQUITY RATIO AVG 5Y
-1.05
DEBT TO EQUITY RATIO AVG 10Y
-0.95
DEBT TO EQUITY RATIO AVG 15Y
0.34
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.85%
CURRENT VS 3Y AVG
-15.41%
CURRENT VS 5Y AVG
-134.10%
CURRENT VS 10Y AVG
-156.96%
CURRENT VS 15Y AVG
-811.55%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.14
median of 476 covered companies
CURRENT VS SECTOR MEDIAN
-1851.55%
vs the sector median at left
Ironwood Pharmaceuticals, Inc.
Market Cap
$601.66M
Debt to Equity Ratio
-2.45
TTM Avg
-2.34
3Y Avg
-2.12
5Y Avg
-1.05
Market Cap
$587.34M
Debt to Equity Ratio
0.27
TTM Avg
0.26
3Y Avg
0.14
5Y Avg
0.13
Market Cap
$580.12M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.05
Market Cap
$573.38M
Debt to Equity Ratio
N/A
TTM Avg
4.68
3Y Avg
4.68
5Y Avg
4.68
Market Cap
$559.96M
Debt to Equity Ratio
0.28
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$554.05M
Debt to Equity Ratio
0.02
TTM Avg
0.04
3Y Avg
0.04
5Y Avg
0.04
Market Cap
$642.86M
Debt to Equity Ratio
0.05
TTM Avg
0.13
3Y Avg
0.11
5Y Avg
0.08
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | $601.66M | -2.45 | -2.34 | -2.12 | -1.05 |
| OrthoPediatrics Corp. (KIDS)vs › | $587.34M | 0.27 | 0.26 | 0.14 | 0.13 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $580.12M | 0.00 | 0.01 | 0.01 | 0.05 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | N/A | 4.68 | 4.68 | 4.68 |
| Climb Bio, Inc. (CLYM)vs › | $625.31M | 0.01 | 0.00 | 0.00 | 0.00 |
| CorMedix Inc. (CRMD)vs › | $564.85M | 0.31 | 0.19 | 0.10 | 0.07 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $559.96M | 0.28 | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $554.05M | 0.02 | 0.04 | 0.04 | 0.04 |
| Aura Biosciences, Inc. (AURA)vs › | $642.86M | 0.05 | 0.13 | 0.11 | 0.08 |
| Delcath Systems, Inc. (DCTH)vs › | $546.13M | 0.02 | 0.01 | 0.23 | 0.43 |
Debt/Equity
-2.45
Current Ratio
6.06
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -2.45 |
| 2026-03-31 | -2.75 |
| 2025-12-31 | -2.28 |
| 2025-09-30 | -2.26 |
| 2025-06-30 | -1.94 |
| 2025-03-31 | -1.79 |
| 2024-12-31 | -1.99 |
| 2024-09-30 | -1.97 |
| 2024-06-30 | -1.99 |
| 2024-03-31 | -2.09 |
| 2023-12-31 | -2.07 |
| 2023-09-30 | -2.29 |
| 2023-06-30 | -2.36 |
| 2023-03-31 | 0.59 |
| 2022-12-31 | 0.64 |
| 2022-09-30 | 0.70 |
| 2022-06-30 | 0.78 |
| 2022-03-31 | 1.04 |
| 2021-12-31 | 0.79 |
| 2021-09-30 | 0.81 |
| 2021-06-30 | 0.91 |
| 2021-03-31 | 4.17 |
| 2020-12-31 | 7.24 |
| 2020-09-30 | 75.95 |
| 2020-06-30 | -12.01 |
| 2020-03-31 | -6.11 |
| 2019-12-31 | -4.62 |
| 2019-09-30 | -2.99 |
| 2019-06-30 | -1.97 |
| 2019-03-31 | -2.10 |
| 2018-12-31 | -2.11 |
| 2018-09-30 | -2.07 |
| 2018-06-30 | -9.26 |
| 2018-03-31 | -22.36 |
| 2017-12-31 | 40.63 |
| 2017-09-30 | -22.55 |
| 2017-06-30 | 80.69 |
| 2017-03-31 | 13.14 |
| 2016-12-31 | 5.59 |
| 2016-09-30 | 6.36 |
| 2016-06-30 | 4.63 |
| 2016-03-31 | 4.17 |
| 2015-12-31 | 4.01 |
| 2015-09-30 | 3.81 |
| 2015-06-30 | 2.73 |
| 2015-03-31 | 2.56 |
| 2014-12-31 | 2.00 |
| 2014-09-30 | 1.65 |
| 2014-06-30 | 1.26 |
| 2014-03-31 | 0.95 |
| 2013-12-31 | 4.68 |
| 2013-09-30 | 2.13 |
| 2013-06-30 | 1.26 |
| 2013-03-31 | 2.99 |
| 2012-12-31 | 0.00 |
| 2012-09-30 | 0.00 |
| 2012-06-30 | 0.00 |
| 2012-03-31 | 0.00 |
| 2011-12-31 | 0.01 |
| 2011-09-30 | 0.01 |
| 2011-06-30 | 0.01 |
| 2011-03-31 | 0.01 |
| 2010-12-31 | 0.00 |
| 2010-09-30 | 0.00 |
| 2010-06-30 | 0.02 |
| 2010-03-31 | 0.02 |
| 2009-12-31 | -0.01 |
| 2009-09-30 | 0.19 |
| 2009-06-30 | 0.00 |
| 2009-03-31 | 0.00 |
| 2008-12-31 | -0.01 |
